Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedMay 19, 2026
DataAggregated Company Financials
Companies69
  • 7D5.3%
  • 3M-0.2%
  • 1Y27.5%
  • YTD17.3%

Over the last 7 days, the Biotech industry has risen 5.2%, driven by gains from PharmaEssentia of 14%. During this same period, the HanchorBio underperformed, falling 8.5%. This means that the industry has gained 30% over the past year. Looking forward, earnings are forecast to grow by 55% annually.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 19 May 2026NT$685.1bNT$36.8b-NT$9,177,968,000.0028.9x-74.6x18.6x
Thu, 16 Apr 2026NT$646.3bNT$34.6b-NT$10,722,615,500.0033.2x-60.3x18.7x
Sat, 14 Mar 2026NT$644.0bNT$33.8b-NT$9,946,348,500.0027.3x-64.7x19x
Mon, 09 Feb 2026NT$683.6bNT$33.4b-NT$8,679,898,000.0029.8x-78.8x20.5x
Wed, 07 Jan 2026NT$566.6bNT$33.4b-NT$7,030,488,000.0030.1x-80.6x17x
Fri, 05 Dec 2025NT$569.2bNT$33.4b-NT$6,850,221,000.0029.6x-83.1x17.1x
Sun, 02 Nov 2025NT$542.9bNT$32.2b-NT$8,364,979,000.0034.7x-64.9x16.8x
Tue, 30 Sep 2025NT$548.3bNT$32.2b-NT$8,364,979,000.0038.3x-65.6x17x
Thu, 28 Aug 2025NT$532.9bNT$32.2b-NT$8,215,909,000.0033.8x-64.9x16.5x
Sat, 26 Jul 2025NT$504.3bNT$31.3b-NT$6,301,777,000.0031.3x-80x16.1x
Mon, 23 Jun 2025NT$500.2bNT$30.2b-NT$6,460,452,000.0037.2x-77.4x16.5x
Wed, 21 May 2025NT$495.0bNT$30.0b-NT$6,443,317,000.0031.4x-76.8x16.5x
Fri, 18 Apr 2025NT$469.4bNT$28.1b-NT$7,302,014,000.0028.9x-64.3x16.7x
Sun, 16 Mar 2025NT$527.9bNT$28.1b-NT$8,214,097,000.0032.5x-64.3x18.8x
Tue, 11 Feb 2025NT$573.2bNT$24.8b-NT$10,902,841,000.0039.4x-52.6x23.1x
Thu, 09 Jan 2025NT$563.5bNT$24.8b-NT$10,902,841,000.0036.2x-51.7x22.7x
Sat, 07 Dec 2024NT$514.9bNT$24.8b-NT$10,848,531,000.0037.2x-47.5x20.8x
Mon, 04 Nov 2024NT$542.4bNT$23.5b-NT$10,829,095,000.0042.1x-50.1x23.1x
Wed, 02 Oct 2024NT$551.8bNT$23.5b-NT$10,829,095,000.0036x-51x23.5x
Fri, 30 Aug 2024NT$582.4bNT$23.4b-NT$10,878,156,000.0034.6x-53.5x24.8x
Sun, 28 Jul 2024NT$566.6bNT$21.9b-NT$11,110,100,000.0043.2x-51x25.8x
Tue, 25 Jun 2024NT$520.1bNT$21.9b-NT$11,110,643,000.0041.7x-46.8x23.7x
Thu, 23 May 2024NT$487.1bNT$21.9b-NT$10,991,943,000.0042.5x-44.3x22.2x
Sat, 20 Apr 2024NT$443.2bNT$20.9b-NT$12,201,535,000.0049x-36.3x21.2x
Mon, 18 Mar 2024NT$431.0bNT$21.0b-NT$10,203,772,000.0042.9x-42.2x20.5x
Wed, 14 Feb 2024NT$436.3bNT$19.9b-NT$9,857,794,000.0040.5x-44.3x21.9x
Fri, 12 Jan 2024NT$456.2bNT$19.8b-NT$9,748,146,000.0039x-46.8x23.1x
Sun, 10 Dec 2023NT$478.2bNT$19.9b-NT$9,737,975,000.0043.3x-49.1x24.1x
Tue, 07 Nov 2023NT$484.2bNT$18.4b-NT$10,823,013,000.0050.4x-44.7x26.3x
Thu, 05 Oct 2023NT$479.1bNT$18.3b-NT$10,774,226,000.0043.6x-44.5x26.2x
Sat, 02 Sep 2023NT$493.2bNT$18.3b-NT$10,596,353,000.0043.3x-46.5x26.9x
Mon, 31 Jul 2023NT$472.0bNT$18.6b-NT$10,793,316,000.0044.2x-43.7x25.4x
Wed, 28 Jun 2023NT$473.6bNT$18.7b-NT$10,709,428,000.0043.8x-44.2x25.4x
Fri, 26 May 2023NT$497.2bNT$19.3b-NT$9,973,530,000.0045.6x-49.9x25.8x
Price to Earnings Ratio

-49.9x


Total Market Cap: NT$497.2bTotal Earnings: -NT$9,973,530,000.00Total Revenue: NT$19.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -56.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 21.2x is higher than the industry's current PS ratio of 18.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 24% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market-2.22%
Healthcare-0.077%
Biotech5.30%
Biotech5.30%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6446 PharmaEssentiaNT$793.0011.5%
+NT$30.8b		75.7%PE49.7x
7762 Pet Pharm BiotechNT$58.5022.0%
+NT$603.8m		12.5%PE134x
3176 Medigen BiotechnologyNT$35.3511.2%
+NT$494.5m		11.2%PS3.1x
6976 AcepodiaNT$13.806.2%
+NT$465.8m		-25.4%PS43430.4x
6617 Gongwin Biopharm HoldingsNT$65.005.7%
+NT$429.2m		-42.0%PS208.2x

Latest News

4728
NT$384.50
Sunmax Biotechnology
7D
0.9%
1Y
-6.4%
4168
NT$25.05
GlycoNex Incorporation
7D
11.3%
1Y
33.2%
6617
NT$65.00
Gongwin Biopharm Holdings
7D
5.7%
1Y
-42.0%
6446
NT$793.00
PharmaEssentia
7D
11.5%
1Y
75.7%
4147
NT$49.30
TaiMed Biologics
7D
-1.6%
1Y
-36.8%
6492
NT$45.00
Senhwa Biosciences
7D
-9.9%
1Y
27.7%
4169
NT$150.50
TCM Biotech International
7D
-3.2%
1Y
195.1%
6949
NT$670.00
Pell Bio-Med Technology
7D
-1.5%
1Y
427.6%
7827
NT$130.50
HanchorBio
7D
-6.1%
1Y
n/a
7832
NT$12.25
Intelligene
7D
-4.7%
1Y
-6.5%
6945
NT$168.00
AP Biosciences
7D
-2.6%
1Y
221.8%
6976
NT$13.80
Acepodia
7D
6.2%
1Y
-25.4%
7762
NT$58.50
Pet Pharm Biotech
7D
22.0%
1Y
12.5%
3176
NT$35.35
Medigen Biotechnology
7D
11.2%
1Y
11.2%
6892
NT$27.40
Taiwan Bio Therapeutics
7D
9.2%
1Y
-8.5%
6696
NT$396.50
Lin BioScience
7D
-5.0%
1Y
189.4%